Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant-Reference-Cited by-同舟云学术

Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant

Published:2016-06-14 Issue:15 Volume:76 Page:4579-4591
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Richmond Jennifer,Robbins Alissa,Evans Kathryn,Beck Dominik,Kurmasheva Raushan T.,Billups Catherine A.,Carol Hernan,Heatley Sue,Sutton Rosemary,Marshall Glenn M.,White Deborah,Pimanda John,Houghton Peter J.,Smith Malcolm A.,Lock Richard B.

Funder

NCI

Australian National Health and Medical Research Council

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening;Heliyon;2024-07

2. Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia;Blood;2024-05-23

3. Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia;HemaSphere;2023-05-26

4. Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article;Annals of Hematology;2023-05-02

5. X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL;EMBO Molecular Medicine;2022-11-23